A Norwegian health worker hospitalized two days ago with thrombosis after receiving the first dose of the vaccine from AstraZeneca against him coronavirus covid-19 He has died, the authorities of this Nordic country reported today.

This is a woman under 50 years of age, with no previous ailments, who had been vaccinated a week before and who presented an “unusual” clinical picture, as did two other health workers, all admitted last weekend at the University Hospital from Oslo.

“They have a very rare combination of low platelets, thrombi in small and large blood vessels, and bleeding. Other cases with similar symptoms have appeared in several European countries ”, Steinar Madsen, the director of the Norwegian Medicines Agency, told a press conference.

Norwegian health authorities They are now investigating whether there is a direct relationship between the vaccine and the three cases, which Madsen explained show common traits.

“The Medicines Agency will thoroughly analyze the cases of thrombi and bleeding in vaccines against covid-19 in use in Norway. We ask all health personnel who suspect unexpected or serious effects after vaccination to report it as quickly as possible,” Madsen stated.

Norway temporarily suspended last Thursday in a preventive way the application of that vaccine hours after it was done Denmark, which recorded a death in a 60-year-old woman.

That decision was subsequently joined by Iceland, Ireland, Bulgaria and the Netherlands, while other countries, such as Austria, Estonia, Latvia, Lithuania and Luxembourg, had withdrawn a specific batch of the vaccine days before when detecting cases of thrombosis.

The European Medicines Agency (EMA) recommended last week to continue administering the vaccine, considering that “the benefits of the vaccine continue to outweigh its risks.”

The EMA safety committee (PRAC) concluded that, for now, “there is no indication that vaccination has caused these conditions, which are not listed as side effects of this vaccine,” although it has launched an investigation, at as well as state agencies in various European countries.

Categorized in: